RxDoctor Payments Data

Grainne O Malley, MD

Internal Medicine · West Lafayette, INNPI 1407230501

Payments from drug & device makers

$821in general payments, 2019–2025

Across 49 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$314
  • AstraZeneca$105
  • Edwards Lifesciences$97
  • Lilly USA, LLC$69
  • Johnson & Johnson$54
  • Mylan Specialty L.p.$48
  • plus $134 from 6 others

What the payments were for

  • Food & beverage$821100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$821 in reported general payments places this provider in the 70th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$134,059
Medicare patients
637
Services billed
1,365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$124,705
MounjaroTirzepatide79$99,250
FarxigaDapagliflozin Propanediol58$81,894
EliquisApixaban61$74,490
JardianceEmpagliflozin47$62,918
XareltoRivaroxaban27$44,699
TrulicityDulaglutide29$37,249
Praluent PenAlirocumab15$18,060
Repatha SureclickEvolocumab14$15,084
Potassium Chloride151$14,334
Tresiba Flextouch U-100Insulin Degludec22$13,788
TradjentaLinagliptin13$11,891
MyrbetriqMirabegron11$10,550
Atorvastatin Calcium869$9,769
Levothyroxine Sodium335$4,386

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$69$136,499108 claims
Novo NordiskOzempic$13$124,705103 claims
AstraZenecaFarxiga$105$81,89458 claims
PfizerEliquis, Paxlovid$22$75,92075 claims
Boehringer IngelheimJardiance, Tradjenta$47$74,80960 claims
Johnson & JohnsonXarelto$54$44,69927 claims
Astellas Pharma US IncMyrbetriq$28$10,55011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,747 internal medicine providers in Indiana.

Other internal medicine in West Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →